Predictive power of quasimesenchymal phenotype in epithelial malignancies https://doi.org/10.1038/s41379-018-0196-2
Mahadevan et al. used RNA in situ hybridization probes for epithelial-mesenchymal transition related genes expressed in circulating tumor cells to assess the role of this transition in metastasis. Using a panel of 158 pancreatic ductal adenocarcinomas and 205 colonic adenocarcinomas, the group assessed expression of their RNA probes, using SMAD4 expression as a biomarker. They developed an expression signature that signified epithelial phenotypes and a second that signified quasimesenchymal phenotypes and showed that the quasimesenchymal phenotype, in both pancreatic and colonic adenocarcinoma samples, correlated with significantly shorter disease-specific and metastasis-free survival. SMAD4 loss demonstrated the same thing, but proved to be a less robust predictor of metastases. Chemotherapy-naïve epithelial tumors showed a superior metastasis-free survival when compared to chemotherapynaïve quasimesenchymal tumors. This could allow predictive modeling in clinical care and better assessment for clinical trial entry to better target current therapeutic strategies.
T-cell infiltration in DLBCL patients
https://doi.org/10.1038/s41379-018-0193-5
Anti-PD-1/PD-L1 immunotherapy is now a cornerstone in oncology; however, the prognostic significance of PD-1/ Ye et al. demonstrate that temporal and spatial control of heart maturation is regulated by these factors. The relative levels of each family member throughout cardiac development, along with their relative locations, define an intensity gradient of TCF7L2 that opposes β-catenin in fetal hearts. Wnt signaling differentially regulates LEF1, TCF7, TCF7L1, and TCF7L2 expression in response to Apc deletion, and this activation is responsible for target gene activation by switching between enhancers and recruiting pSMADs. The network is a tightly balanced and interwoven system that when dysregulated can lead to proliferation defects and congenital heart abnormalities.
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11 Bacterial strains from Rnf5 −/− mice restrict melanoma growth in Wt mice
Mice lacking the ubiquitin ligase RNF5 were shown to exhibit attenuated activation of the unfolded protein response (UPR) components, which has downstream effects on inflammasome, recruitment of dendritic cells and expression of antimicrobial peptides in intestinal epithelial cells. Curiously, reduced UPR expression is also seen in both mouse and human melanoma specimens that responded to immune checkpoint therapy. A subset of 11 bacterial strains were identified as being enriched in Rnf5 −/− mice. These specific bacteria, when introduced orally to germ-free WT mice, conferred a previously unseen antitumor immunity and restricted melanoma growth through increased expression of Toll-like receptors. This study identifies an unexpected relationship between the UPR and gut microbiome and opens doors for further analysis of the relationship between the UPR, gut microbiota and immune checkpoint activity in the clinic.
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Manipulation of gut microbiome in metabolic diseases
Data are accumulating that link the human gut microbiome to immune function and metabolic disease, including type 2 diabetes and obesity. Sanna et al show a causal effect of butyrate-producing activity of the gut following a glucose-tolerance test, with specific bacteria increasing in abundance in sharp correlation with butyrate abundance. Using bidirectional Mendelian randomization on a normoglycemic patient group, 17 traits were identified to increase fecal propionate levels and to be causally associated with an increase in body mass index. Larger sample sizes will be required to fully assess microbiome features and better understand the interplay between the gut microbiome and host metabolism. This group explored whether manipulation of the gut microbiome might offer an alternative to pharmacological interventions. Should such manipulation be demonstrated to lead to clinical benefit, it could represent an important avenue of intervention in common metabolic diseases.
